Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...

"Trump, for whatever reason, is perceived amongst conservative men as the pinnacle of masculinity," one political science ...

A man from Brighton has spoken out after the NHS agreed to offer a life-extending drug to more men with prostate cancer. Currently only those with prostate cancer that has spread can get abiraterone ...

NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...

Men with high‑risk locally advanced prostate cancer in England will soon be offered the drug abiraterone on the NHS, ...

Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...

Thousands more men with prostate cancer will be eligible for a life-extending drug on the NHS. The move means the drug, known ...

For the first time, patients whose prostate cancer has not spread will be eligible for the drug abiraterone in England, after ...

The NHS has expanded access to a prostate cancer drug across England in a move which could stop 8,000 former cancer patients from being told their illness has returned.

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...